Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-10-16

Clinical Trial Update: Autoimmune Diabetes Accelerator Prevention Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating autoimmune diabetes accelerator prevention in a prediabetic state has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Exeter | Conditions: Prediabetic State | Phase 4 | Status: WITHDRAWN